Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  American Journal of Psychiatry

• Publication date

  2006-12-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1176/AJP.2006.163.12.2164PMID 17151169PMCID PMC1780275
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Postnatal ontogeny of hippocampal expression of the mineralocorticoid and glucocorticoid receptors in the common marmoset monkey

  2005cited by this paper
• Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.

  2004cited by this paper
• Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stress.

  2004cited by this paper
• An active and socially integrated lifestyle in late life might protect against dementia.

  2004cited by this paper
• Changes in hippocampal volume and shape across time distinguish dementia of the Alzheimer type from healthy aging☆

  2003cited by this paper
• Chronic administration of corticosterone impairs spatial reference memory before spatial working memory in rats.

  2003cited by this paper
• Cell Proliferation in Adult Hippocampus is Decreased by Inescapable Stress: Reversal by Fluoxetine Treatment

  2003cited by this paper
• Rates of progression in mild cognitive impairment and early Alzheimer’s disease

  2002cited by this paper
• Mifepristone (RU 486) for Alzheimer's disease.

  2002cited by this paper
• Increased Levels of Adrenocortical and Gonadal Hormones in Mild to Moderate Alzheimer’s Disease

  2002cited by this paper
• Slowing the progression of cognitive decline in alzheimer’s disease using mifepristone

  2002cited by this paper
• Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40).

  2002cited by this paper
• Mild cognitive impairment represents early-stage Alzheimer disease.

  2001cited by this paper
• Estrogen (E2) and glucocorticoid (Gc) effects on microglia and A beta clearance in vitro and in vivo.

  2001cited by this paper
• The neurobiology of stress: from serendipity to clinical relevance.

  2000influential reference
• Glucocorticoids and the ageing hippocampus

  2000cited by this paper
• Distribution of Corticosteroid Receptors in the Rhesus Brain: Relative Absence of Glucocorticoid Receptors in the Hippocampal Formation

  2000cited by this paper
• Glucocorticoid and mineralocorticoid receptor mRNA expression in squirrel monkey brain.

  2000cited by this paper
• Plasma cortisol levels in elderly female subjects with Alzheimer's disease: a cross-sectional and longitudinal study.

  2000cited by this paper
• Depression Duration But Not Age Predicts Hippocampal Volume Loss in Medically Healthy Women with Recurrent Major Depression

  1999cited by this paper
• Neuropeptide abnormalities in patients with early Alzheimer disease.

  1999cited by this paper
• Rapid glucocorticoid effects on excitatory amino acid levels in the hippocampus: a microdialysis study in freely moving rats

  1999cited by this paper
• Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease

  1999cited by this paper
• Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease

  1998cited by this paper
• Hypothalamic-pituitary-adrenal axis dysfunction in Alzheimer's disease: lack of association between longitudinal and cross-sectional findings.

  1998cited by this paper
• Cortisol levels during human aging predict hippocampal atrophy and memory deficits

  1998cited by this paper
• Cognitive and Noncognitive Symptoms in Dementia Patients: Relationship to Cortisol and Dehydroepiandrosterone

  1998cited by this paper
• Stress, glucocorticoids and structural plasticity of the hippocampus.

  1998cited by this paper
• Cortisol levels during human aging predict hippocampal atrophy and memory deficits

  1998cited by this paper
• Relating anatomy to function in Alzheimer's disease

  1998cited by this paper
• Chronic corticosterone treatment induces parallel changes in N-methyl-D-aspartate receptor subunit messenger RNA levels and antagonist binding sites in the hippocampus.

  1997cited by this paper
• Cortisol secretion and Alzheimer's disease progression.

  1997cited by this paper
• Clinical Dementia Rating training and reliability in multicenter studies

  1997cited by this paper
• Hippocampal atrophy in recurrent major depression.

  1996cited by this paper
• Clinical and Magnetic Resonance Imaging Correlates of Hypothalamic–Pituitary–Adrenal Axis Function in Depression and Alzheimer's Disease

  1996cited by this paper
• Longitudinal study of basal cortisol levels in healthy elderly subjects: evidence for subgroups.

  1996cited by this paper
• Cortical and subcortical neuropeptides in Alzheimer's disease.

  1994cited by this paper
• Basal cortisol levels and cognitive deficits in human aging

  1994cited by this paper
• The Clinical Dementia Rating (CDR)

  1993cited by this paper
• Rapid Communication: Adrenalectomy Attenuates Stress‐Induced Elevations in Extracellular Glutamate Concentrations in the Hippocampus

  1993cited by this paper
• Stress, the Aging Brain, and the Mechanisms of Neuron Death

  1992cited by this paper
• Stress induces atrophy of apical dendrites of hippocampal CA3 pyramidal neurons.

  1992cited by this paper
• The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis.

  1991cited by this paper
• The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease.

  1991cited by this paper
• Hypothalamic-pituitary-adrenal activity in aged, cognitively impaired and cognitively unimpaired rats

  1990cited by this paper
• Mild senile dementia of the alzheimer type: 2. Longitudinal assessment

  1988cited by this paper
• Abnormal cortisol response in Alzheimer's disease linked to hippocampal atrophy.

  1988cited by this paper
• Reliability of the Washington University Clinical Dementia Rating.

  1988cited by this paper
• Cortisol and Alzheimer's disease, I: Basal studies.

  1986cited by this paper
• Two-stage analysis based on a mixed model: large-sample asymptotic theory and small-sample simulation results

  1985cited by this paper
• Random-effects models for longitudinal data.

  1982cited by this paper
• Development and validation of a geriatric depression screening scale: a preliminary report.

  1982cited by this paper
• Hippocampal aging and adrenocorticoids: quantitative correlations.

  1978cited by this paper

• Preclinical amyloid pathology is associated with anxiety but not depression in cognitively normal older adults: Evidence for differential neuropsychiatric pathways

  2026cites this paper
• Effect of cognitive training on cortisol levels in patients with neurocognitive disorders

  2026cites this paper
• Stress-related neurodegenerative diseases: Molecular mechanisms implicated in neurodegeneration and therapeutic strategies.

  2025cites this paper
• What Is the Role of Glucocorticoids in the Effects of Stress on the Brain?

  2025cites this paper
• Presenilin 2 regulates corticosterone-induced autophagic death of adult hippocampal neural stem cells

  2025cites this paper
• Chronic social isolation-unpredictable stress induces early-onset cognitive deficits and exacerbates Aβ accumulation in the 5xFAD mouse model of Alzheimer’s disease

  2025cites this paper
• Glucocorticoids regulate small extracellular vesicle (sEV) release via activation of nSMase2

  2025cites this paper
• Capsaicin evoked cardiopulmonary reflexes and heart rate variability responses are attenuated in a rat model of dementia induced by streptozotocin

  2025cites this paper
• Hypothalamic imaging in Alzheimer's disease and Lewy body dementia: A systematic review and meta-analysis.

  2025cites this paper
• BACE1 as an early biomarker and its relevance to risk factors for Alzheimer's disease.

  2025cites this paper
• Advancing Alzheimer's disease pharmacotherapy: efficacy of glucocorticoid modulation with dazucorilant (CORT113176) in preclinical mouse models

  2025cites this paper
• Hormonal contraceptives modulate resilience to psychiatric and neurodegenerative disease.

  2025cites this paper
• Experimental laboratory models as tools for understanding modifiable dementia risk

  2024cites this paper
• The multiple roles of chronic stress and glucocorticoids in Alzheimer's disease pathogenesis.

  2024cites this paper
• Circadian rhythm of brain‐derived neurotrophic factor in serum and plasma

  2024cites this paper
• Revealing the heterogeneity of plasma protein and cognitive decline trajectory among Mild Cognitive Impairment patients by clustering of brain atrophy features

  2024cites this paper
• Convergent effects of synthetic glucocorticoid dexamethasone and amyloid beta in human olfactory neurosphere‐derived cells

  2024cites this paper
• Allostatic load measures in older adults with subjective cognitive decline and mild cognitive impairment: A cross-sectional analysis from the Brazilian Memory and Aging Study.

  2024cites this paper
• Evaluation of the biodistribution and preliminary safety profile of a novel brain-targeted manganese dioxide-based nanotheranostic system for Alzheimer’s disease

  2024cites this paper
• Lifetime Stressful Events Associated with Alzheimer's Pathologies, Neuroinflammation and Brain Structure in a Risk Enriched Cohort

  2024cites this paper
• The olfactory bulb: A neuroendocrine spotlight on feeding and metabolism

  2024cites this paper
• Aging or chronic stress impairs working memory and modulates GABA and glutamate gene expression in prelimbic cortex

  2024cites this paper
• Glucocorticoid receptor signaling in the brain and its involvement in cognitive function

  2024cites this paper
• Brain 11β-Hydroxysteroid Dehydrogenase Type 1 Occupancy by Xanamem™ Assessed by PET in Alzheimer’s Disease and Cognitively Normal Individuals

  2024cites this paper
• Sex-dependent effects of acute stress on amyloid-β in male and female mice.

  2023cites this paper
• The fibroblast growth factor system in cognitive disorders and dementia

  2023cites this paper
• Neurobiological Effects of Chemical Compounds of Species of the Genus Astragalus L. and Prospects for Their Use in Medicine (Review)

  2023cites this paper
• Resilience, Stress, and Cortisol Predict Cognitive Performance in Older Adults

  2023cites this paper
• Serum cortisol is negatively related to hippocampal volume, brain structure, and memory performance in healthy aging and Alzheimer’s disease

  2023cites this paper
• The effect of plasma cortisol on hippocampal atrophy and clinical progression in mild cognitive impairment

  2023cites this paper
• Anxiety and Alzheimer’s disease pathogenesis: focus on 5-HT and CRF systems in 3xTg-AD and TgF344-AD animal models

  2023cites this paper
• Hypothalamus and amyotrophic lateral sclerosis: potential implications in sleep disorders

  2023influential citation
• Hormones and Aging: An Endocrine Society Scientific Statement.

  2023cites this paper
• Using LC-MS/MS to Determine Salivary Steroid Reference Intervals in a European Older Adult Population

  2023cites this paper
• In vitro methods to assess 11β-hydroxysteroid dehydrogenase type 1 activity.

  2023cites this paper
• Sex Differences in Stress Response: Classical Mechanisms and Beyond

  2023cites this paper
• Chemobrain: An accelerated aging process linking adenosine A2A receptor signaling in cancer survivors.

  2023cites this paper
• 11β‐Hydroxysteroid dehydrogenase and the brain: Not (yet) lost in translation

  2023cites this paper
• Chronic Stress, Depression, and Alzheimer's Disease: The Triangle of Oblivion.

  2023cites this paper
• Life Course Religious Attendance and Cognitive Health at Midlife: Exploring Gendered Contingencies

  2023cites this paper
• Neural Circuit Mechanisms Underlying the Exacerbation of Alzheimer’s Disease by Chronic Stress

  2023cites this paper
• The Role of Steroidomics in the Diagnosis of Alzheimer’s Disease and Type 2 Diabetes Mellitus

  2023cites this paper
• Brain Health Indicators Following Acute Neuro-Exergaming: Biomarker and Cognition in Mild Cognitive Impairment (MCI) after Pedal-n-Play (iPACES)

  2023cites this paper
• Cerebrospinal fluid levels of hypothalamic-pituitary-adrenal axis hormones in MCI and dementia due to Alzheimer’s disease: a systematic review

  2023cites this paper
• Personality traits, cognitive states, and mortality in older adulthood.

  2022cites this paper
• Hypothalamic-pituitary-adrenal (HPA) axis activity and anxiety-like behavior during aging: a test of the glucocorticoid cascade hypothesis in amyloidogenic APPswe/PS1dE9 mice.

  2022cites this paper
• Feasibility of Hair Cortisol as a Biomarker of Chronic Stress in People With Dementia

  2022influential citation
• Chronic glucocorticoid exposure accelerates Aβ generation and neurotoxicity by activating calcium-mediated CN-NFAT1 signaling in hippocampal neurons in APP/PS1 mice.

  2022cites this paper
• Association of marital status with cognitive function in Chinese hypertensive patients: a cross-sectional study

  2022cites this paper
• Psychobiological Evaluation of Day Clinic Treatment for People Living With Dementia – Feasibility and Pilot Analyses

  2022cites this paper
• Circadian Rhythm Changes in Healthy Aging and Mild Cognitive Impairment

  2022cites this paper
• Neurovascular Dysfunction in Diverse Communities With Health Disparities—Contributions to Dementia and Alzheimer’s Disease

  2022cites this paper
• Diurnal dynamic range as index of dysregulation of system dynamics. A cortisol examplar using data from the Study of Midlife in the United States.

  2022cites this paper
• Is Stress an Overlooked Risk Factor for Dementia? A Systematic Review from a Lifespan Developmental Perspective

  2022cites this paper
• Psychobiological Monitoring of a Home-Based Dyadic Intervention for People Living with Dementia and Their Caregivers: Added Value to Evaluate Treatment Success and Understand Underlying Mechanisms

  2022cites this paper
• A life course approach to understanding stress exposures and cognitive function among middle-aged and older adults.

  2022cites this paper
• The effects of synthetic glucocorticoid treatment for inflammatory disease on brain structure, function, and dementia outcomes: A systematic review.

  2022cites this paper
• The connections of Locus Coeruleus with hypothalamus: potential involvement in Alzheimer’s disease

  2021cites this paper
• Anxiety and Alzheimer's disease: Behavioral Analysis and Neural Basis in Rodent Models of Alzheimer's-Related Neuropathology.

  2021cites this paper
• Alzheimer’s pathogenic mechanisms and underlying sex difference

  2021cites this paper
• Chronic stress and Alzheimer's disease

  2021cites this paper
• The Immunopathogenesis of Alzheimer’s Disease Is Related to the Composition of Gut Microbiota

  2021cites this paper
• Corticosteroid-binding-globulin (CBG)-deficient mice show high pY216-GSK3β and phosphorylated-Tau levels in the hippocampus

  2021cites this paper
• Circadian Rhythms of the Hypothalamus: From Function to Physiology

  2021cites this paper
• Endocrine dysfunction and cognitive impairment.

  2021cites this paper
• Depression and Dementia: The Role of Cortisol and Vascular Brain Lesions. AGES-Reykjavik Study

  2021cites this paper
• Differential Effects of Chronic Stress on Anxiety-like Behavior and Contextual Fear Conditioning in the TgF344-AD Rat Model of Alzheimer's disease.

  2021cites this paper
• Chronic Glucocorticoids Consumption Triggers and Worsens Experimental Alzheimer’s Disease-Like Pathology by Detrimental Immune Modulations

  2021cites this paper
• Aging, Social Distancing, and COVID-19 Risk: Who is more Vulnerable and Why?

  2021cites this paper
• Chinese Herbal Medicine Adjusting Brain Microenvironment via Mediating Central Nervous System Lymphatic Drainage in Alzheimer’s Disease

  2021cites this paper
• Association of Stressful Life Events with Dementia in North Indian Populations

  2021cites this paper
• Role of the gut microbiome in Alzheimer’s disease

  2021cites this paper
• Intact circadian rhythm despite cortisol hypersecretion in Alzheimer's disease: A meta-analysis.

  2021cites this paper
• Association of Stress with Risk of Dementia and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis

  2021cites this paper
• Cumulative Stress Burden and Cognitive Function in African American Adults Living in Low-Income Neighborhoods

  2021cites this paper
• Current Views on the Role of Stress in the Pathogenesis of Chronic Neurodegenerative Diseases

  2021cites this paper
• Современные представления о роли стресса в патогенезе хронических нейродегенеративных заболеваний

  2021cites this paper
• Chronic stress and Alzheimer's disease: the interplay between the hypothalamic–pituitary–adrenal axis, genetics and microglia

  2021cites this paper
• Genotype Load Modulates Amyloid Burden and Anxiety-Like Patterns in Male 3xTg-AD Survivors despite Similar Neuro-Immunoendocrine, Synaptic and Cognitive Impairments

  2021cites this paper
• Serum Corticosterone and Insulin Resistance as Early Biomarkers in the hAPP23 Overexpressing Mouse Model of Alzheimer’s Disease

  2021cites this paper
• Relationship between cortisol, Interleukin-6 and homocysteine in Alzheimer's disease

  2021influential citation
• Peptic ulcer does not increase the risk of dementia

  2020cites this paper
• Endocrine stress responsivity and social memory in 3xTg-AD female and male mice: A tale of two experiments.

  2020cites this paper
• Cortisol hypersecretion and the risk of Alzheimer's disease: A systematic review and meta-analysis.

  2020cites this paper
• Development of Classification Models for the Prediction of Alzheimer’s Disease Utilizing Circulating Sex Hormone Ratios

  2020cites this paper
• Stress and Alzheimer's Disease: A Senescence Link?

  2020cites this paper
• Traumatic and Degenerative Hypothalamic Diseases

  2020cites this paper
• Involvement of Lipids in Alzheimer’s Disease Pathology and Potential Therapies

  2020cites this paper
• Trait anxiety, a personality risk factor associated with Alzheimer's Disease.

  2020cites this paper
• The effects of stress on cardiovascular disease and Alzheimer's disease: Physical exercise as a counteract measure.

  2020cites this paper
• Role of Mind Diet in Preventing Dementia and Alzheimers Disease

  2020cites this paper
• Body Mass Index and Age Effects on Brain 11β-Hydroxysteroid Dehydrogenase Type 1: a Positron Emission Tomography Study

  2020cites this paper
• 11β-hydroxysteroid dehydrogenase type 1 inhibitor use in human disease- a systematic review and narrative synthesis.

  2020cites this paper
• A Systematic Review of the Association Between Psychological Stress and Dementia Risk in Humans

  2020cites this paper
• miRNA-31 Improves Cognition and Abolishes Amyloid-β Pathology by Targeting APP and BACE1 in an Animal Model of Alzheimer’s Disease

  2020cites this paper
• Cognitive performance in patients with chronic tension-type headache and its relation to neuroendocrine hormones

  2020cites this paper
• Cortisol reactivity to a psychosocial stressor significantly increases the risk of developing Cognitive Impairment no Dementia five years later.

  2020cites this paper
• Diurnal Cortisol Slope Mediates the Association Between Affect and Memory Retrieval in Older Adults With Mild Cognitive Impairment: A Path-Analytical Study

  2020cites this paper
• Salivary cortisol and five-year change in cognitive performance in non-demented elderly subjects: a population-based study.

  2020cites this paper
• Vaccinium bracteatum Improves Spatial Learning and Memory by Regulating N-methyl-D-aspartate Receptors and Tau Phosphorylation in Chronic Restraint Stress-Induced Memory Impaired Mice.

  2020cites this paper